MESTINON
Generic: PYRIDOSTIGMINE BROMIDE
Bausch Health USManufacturer
ORALRoute
PYRIDOSTIGMINE BROMIDEActive Substance
1965-01-25Original Approval
MESTINON is FDA application NDA015193, sponsored by BAUSCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
MYASTHENIA GRAVIS
846 reports
2
FATIGUE
745 reports
3
DRUG INEFFECTIVE
612 reports
4
ASTHENIA
582 reports
5
OFF LABEL USE
572 reports
6
DIARRHOEA
540 reports
7
HEADACHE
513 reports
8
DYSPNOEA
510 reports
9
NAUSEA
461 reports
10
MUSCULAR WEAKNESS
394 reports